共 50 条
Diagnosis and Treatment of Pleuropulmonary Blastoma-Single Center Experience
被引:11
|作者:
Christosova, Iskra R.
[1
]
Avramova, Boryana E.
[1
]
Drebov, Rosen S.
[2
]
Shivachev, Hristo I.
[2
]
Kamenova, Margarita A.
[3
]
Bobev, Dragan G.
[1
]
Brankov, Ognyan G.
[2
]
机构:
[1] Specialized Hosp Pediat Oncohematol, Sofia 1527, Bulgaria
[2] Univ Hosp Emergency Med Pirogov, Clin Pediat Surg, Sofia, Bulgaria
[3] Univ Hosp Emergency Med Pirogov, Sect Pathol, Sofia, Bulgaria
关键词:
pleuropulmonary blastoma;
dysembryonic neoplasm;
combined modality treatment;
myeloablative chemotherapy;
PULMONARY BLASTOMA;
DICER1;
MUTATIONS;
LUNG-TUMORS;
CHILDHOOD;
CHEMOTHERAPY;
CHILDREN;
PATIENT;
ADULT;
D O I:
10.1002/ppul.23047
中图分类号:
R72 [儿科学];
学科分类号:
100202 ;
摘要:
Pleuropulmonary blastoma (PPB) is a rare and potentially aggressive intrathoracic disembryonic neoplasm typically occurring in children less than 6 years of age. We assessed the relative incidence, clinical characteristics, treatment outcome, and the prognostic factors for long-term survival in patients with PPB treated at our institution over a 25-year period, and compared these data with reports in the literature. From 1985 to 2010, 11 children (4 males and 7 females), with a median age of 5.4 years (range, 1-12 years) were treated at our hospital. Here we described the main characteristics of these patients, the diagnostic methods, and treatment modalities used. During a median follow-up period of 80, 9 months, the overall survival (OS) and disease-free survival (DFS) rates were 54, 6% and 45, 5%, respectively. Two patients survived for more than 20 years. The main prognostic factors for long-term survival were the diseases type I and II and treatment with radical surgery. Our results show that in order to improve the prognosis of patients with PPB a timely in our opinion and accurate diagnosis needs to be established and treatment should be offered according to the disease type and extend of dissemination. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:698 / 703
页数:6
相关论文